Due to the Covid-19 health risks, many government agencies and businesses across the nation have been and are being affected. FSSolutions is working hard to provide our services in the manner that our clients have come to expect, but please note that delays should be expected.
COVID-19 Resources Page

Recovery Management Services Webinars

 
“MONITORING PROGRAM SPECIMEN SELECTION, EVALUATION AND ISSUES”  Presented By: James L. Ferguson, DO, FASAM, Medical Director, Recovery Management Services

This webinar will include a discussion about specimen concentration concerns, dilute and low creatinine specimens, follow-up testing protocols and recommendations on these issues.


 
SEPTEMBER 15, 2020 / TUESDAY / @2:00-3:00 PM EST – “DRUG & ALCOHOL TESTING, REPORTS, MRO’S ROLE AND YOU” Presented By: James L. Ferguson, DO, FASAM, Medical Director, Recovery Management Services

During this webinar we will discuss the Role of an MRO, different types of drug & alcohol testing, dilute and invalid tests, interpreting a toxicology report, etc.

Objectives:

  • Describe the role of an MRO
  • Compare and contrast the different types of testing used in monitoring programs- Urine, Hair, Nail, Saliva and Blood
  • Discuss the components of a lab report

 
NOVEMBER 10TH, 2020 / TUESDAY / @2:00-3:00 PM EST – “FREQUENTLY ASKED RECOVERY MONITORING QUESTIONS” Presented By: James L. Ferguson, DO, FASAM, Medical Director, Recovery Management Services

What are the most troublesome issues facing recovery monitoring programs? How do these issues impact your participant’s recovery? The importance of staying abreast of evolving drug screening trends is paramount to establishing a solid recovery monitoring program. Please join FSSolutions as James L. Ferguson, DO, DFASAM, MRO, Medical Director, Recovery Management Services addresses the most commonly asked questions and challenging issues facing all recovery monitoring programs. Dr. Ferguson will discuss the questions and concerns he hears most frequently, as well as provide best practices and strategies for dealing with problems as they arise.

As experts in the recovery monitoring space, we receive questions all the time. To benefit our valued partners in the industry, we’ve compiled an in-depth presentation of answers to some of the most frequently asked questions we receive, for example:

  • What is the difference between Cannabidiols Versus Tetrahydrocannabinol?
  • What is the best way to follow up after a dilute test?
  • Why is ETG Positive but PEth Negative?
  • Why use PEth testing?
  • What Laboratories does FSSolutions use?

There will be sufficient time for live Q&A during this webinar. If you have a specific question you would like answered, please submit it ahead of time to skinkle@fssolutions.com and Dr. Ferguson will address it.

REGISTER FOR 2:00 PM SESSION


 

Workforce Solutions Webinars

 

JANUARY 29, 2020 / WEDNESDAY / @2:00 PM EST, “UNUSUAL SITUATIONS IN DRUG TESTING”, Presented By: Dr. Randy Barnett, Chief Medical Review Officer (MRO)

Please join FSSolutions as Dr. Randy Barnett, FSSolutions’ Chief Medical Review Officer (MRO) discusses unusual circumstances that occur during the drug testing process and how they should be handled.

Do you have an unusual situation that you would like Dr. Barnett to include in the discussions? Submit it by email to rdoural@fssolutions.com prior to the webinar.

The discussion will include these situations and more:

  • Canceled – Invalid Results
  • Substituted Specimens
  • Shy Bladder Evaluations
  • Foreign Medications

 
FEBRUARY 4, 2020 / TUESDAY / 1:00 PM EST – AND – FEBRUARY 6, 2020 / THURSDAY / 10:00 AM EST, “PREPARING YOUR ANNUAL MANAGEMENT INFORMATION SYSTEM (MIS) REPORT” – Presented by Regina Doural, CSAPA, General Manager Compliance Services

Please join FSSolutions’ Regina Doural, CSAPA, General Manager Compliance Services, for a presentation and discussion on preparing the required annual MIS report.

Federal Transit Administration (FTA) recipients are required to prepare and maintain an annual summary of their drug and alcohol records using the MIS form.

This webinar will include the following:

  • The proper way to complete the MIS report
  • What to include and what not to include on the MIS report
  • What reports are available to validate your information
  • How to calculate your average number of employees

 
FEBRUARY 26, 2020 / WEDNESDAY / @2:00 PM EST, “FMCSA COMMERCIAL DRIVER’S LICENSE DRUG & ALCOHOL CLEARINGHOUSE” – Presented by Shawn O’Neil, CSAPA, Chief Compliance Officer and Regina Doural, CSAPA, General Manager Compliance Services

Please join FSSolutions’ Shawn O’Neil, CSAPA, Chief Compliance Officer, and Regina Doural, CSAPA, General Manager Compliance Services for a question and answer session on the FMCSA Clearinghouse.

FMCSA’s Commercial Driver’s License Drug and Alcohol Clearinghouse went live on January 6, 2020. In this webinar, FSSolutions will answer some frequently asked questions regarding the Clearinghouse Regulations.

Some questions that will be answered:

  • What am I responsible to enter in the Clearinghouse
  • How do I get my drivers entered in the Clearinghouse
  • What happens if my driver does not use his CDL number
  • How do I see the positive test results the MRO entered
  • How FSSolutions can assist you in meeting these regulatory requirements

 
APRIL 29, 2020 / WEDNESDAY / @1:00 PM EST / “MANAGING YOUR PROGRAM DURING THE COVID-19 CRISIS” – Presented by: Shawn O’Neil, CSAPA, Chief Compliance Officer and Reginal Doural, CSAPA, General Manager Compliance Services

Please join FSSolutions’ Shawn O’Neil, CSAPA, Chief Compliance Officer, and Regina Doural, CSAPA, General Manager Compliance Services for a discussion on the challenges and latest regulatory guidance related to COVID-19.

As part of FSSolutions’ ongoing effort to keep clients informed about the most significant developments stemming from the COVID-19 pandemic, we are offering a webinar focused on issues regarding compliance challenges and solutions.

As if regulatory compliance wasn’t complicated enough, along comes COVID-19, and suddenly organizations are finding new rules, relaxed rules, rule waivers, and more. During this time, the health and safety of you, your staff and the public are paramount. How best to sort through all of this, balancing your employee’s safety with regulations and remain compliant? Our focus is on helping clients anticipate problems, take proactive steps, develop appropriate responses, and execute sound operational plans.

Some topics that will be discussed:

  • What are your options for drug and alcohol testing
  • What Occupational Health Services are affected
  • Can my drivers still re-certify their CDME
  • How is this crisis affecting background check services
  • Do I need to make any changes to my program

 
MAY 21, 2020 / THURSDAY / 1:00 PM EST / “THE NEW NORMAL – RETURNING TO BUSINESS AS USUAL AFTER COVID-19 – Presented by: Shawn O’Neil, CSAPA, Chief Compliance Officer, and Regina Doural, CSAPA, General Manager Compliance Services

As part of FSSolutions’ ongoing effort to keep clients informed about the most significant developments stemming from the COVID-19 pandemic, we are offering a webinar focused on issues regarding compliance challenges and solutions.

Please join FSSolutions’ Shawn O’Neil, CSAPA, Chief Compliance Officer, and Regina Doural, CSAPA, General Manager Compliance Services for a discussion on the challenges and latest regulatory guidance related to COVID-19 and returning to business as usual.

As if regulatory compliance wasn’t complicated enough, along comes COVID-19, and suddenly organizations are finding new rules, relaxed rules, rule waivers, and more. During this time, the health and safety of you, your staff and the public are paramount. Now that stay at home orders are being lifted, and the country is returning to business as usual, a new normal will emerge.

Some topics that will be discussed:

  • Completing the required testing
  • Returning furloughed employees to work
  • Whether changes to your program are needed
  • Establishing that new normal

 
JUNE 23, 2020 / TUESDAY / 2:00 PM EST / “MARIJUANA UPDATE: A DISCUSSION WITH THE MRO” – Presented By: Dr. Randy Barnett, Chief Medical Review Officer

Thirty-three (33) states, District of Columbia and three (3) U.S. territories have passed medical marijuana laws. This webinar will discuss specific states where laws have been passed, legal cases and ruling related to marijuana.

Please join FSSolutions’ Dr. Randy Barnett, Chief Medical Review Officer, for an update and discussion on legal issues and pending and recent marijuana legislation.

Some topics that will be covered:

    • State laws versus federal laws
    • Current trends in state marijuana laws
    • Are you prohibited from drug testing for marijuana?
    • Medical marijuana and employment considerations
    • Cannabidiol (CBD)
    • Recreational marijuana laws

 
SEPTEMBER 23RD, 2020 / WEDNESDAY / 10:00 AM EST / 9:00 AM CST / “ASK THE MRO” – Presented By: Dr. Randy Barnett, FSSolutions’ Chief Medical Review Officer (MRO)

During this webinar, Dr. Barnett will answer some frequently asked questions regarding Drug & Alcohol testing.

Some Questions to be Covered:

  • Can food ingestion cause a positive drug test?
  • What over the counter medications cause a positive drug test?
  • Why did the MRO change a positive result to a negative result?
  • How old is too old for an acceptable prescription?

 
OCTOBER 28, 2020 / WEDNESDAY / @2:00 PM EST / “REGULATORY UPDATES: HAIR TESTING, ORAL FLUID TESTING AND THE NEW FEDERAL CHAIN OF CUSTODY FORM” – Presented By: Shawn O’Neil, CSAPA, Chief Compliance Officer, and Regina Doural, CSAPA, General Manager Compliance Services

This webinar will discuss recent and pending HHS and DOT regulatory actions and how they affect your DOT and NON-DOT programs.

Some topics that will be covered:

  • The importance of the proposed HHS Guidelines
  • Comparison of specimen types
  • Review of Oral Fluid testing guidelines
  • Review of Hair testing guidelines
  • New Federal Chain of Custody Form

REGISTER FOR 2:00 PM SESSION

See All Resources